ARCHIVES

Shorter, Simpler Consent Form Proposed For Phase I Trials

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

AACI Asks NCI for Better Definitions Of Center Types, Development Of Objectives, Priorities

June 25, 1976